These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 22733360

  • 1. Effect of fasudil, a selective inhibitor of Rho kinase activity, in the secondary injury associated with the experimental model of spinal cord trauma.
    Impellizzeri D, Mazzon E, Paterniti I, Esposito E, Cuzzocrea S.
    J Pharmacol Exp Ther; 2012 Oct; 343(1):21-33. PubMed ID: 22733360
    [Abstract] [Full Text] [Related]

  • 2. Evidence for the role of mitogen-activated protein kinase signaling pathways in the development of spinal cord injury.
    Genovese T, Esposito E, Mazzon E, Muià C, Di Paola R, Meli R, Bramanti P, Cuzzocrea S.
    J Pharmacol Exp Ther; 2008 Apr; 325(1):100-14. PubMed ID: 18180375
    [Abstract] [Full Text] [Related]

  • 3. ROCK inhibition with fasudil promotes early functional recovery of spinal cord injury in rats by enhancing microglia phagocytosis.
    Fu PC, Tang RH, Wan Y, Xie MJ, Wang W, Luo X, Yu ZY.
    J Huazhong Univ Sci Technolog Med Sci; 2016 Feb; 36(1):31-36. PubMed ID: 26838736
    [Abstract] [Full Text] [Related]

  • 4. Fasudil, a Rho kinase inhibitor, drives mobilization of adult neural stem cells after hypoxia/reoxygenation injury in mice.
    Ding J, Li QY, Yu JZ, Wang X, Sun CH, Lu CZ, Xiao BG.
    Mol Cell Neurosci; 2010 Feb; 43(2):201-8. PubMed ID: 19913617
    [Abstract] [Full Text] [Related]

  • 5. Antiinflammatory effect of Rho kinase blockade via inhibition of NF-kappaB activation in rheumatoid arthritis.
    He Y, Xu H, Liang L, Zhan Z, Yang X, Yu X, Ye Y, Sun L.
    Arthritis Rheum; 2008 Nov; 58(11):3366-76. PubMed ID: 18975348
    [Abstract] [Full Text] [Related]

  • 6. Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and secondary damage in experimental spinal cord trauma.
    Genovese T, Mazzon E, Muià C, Patel NS, Threadgill MD, Bramanti P, De Sarro A, Thiemermann C, Cuzzocrea S.
    J Pharmacol Exp Ther; 2005 Feb; 312(2):449-57. PubMed ID: 15452194
    [Abstract] [Full Text] [Related]

  • 7. Glycogen synthase kinase-3 beta inhibition reduces secondary damage in experimental spinal cord trauma.
    Cuzzocrea S, Genovese T, Mazzon E, Crisafulli C, Di Paola R, Muià C, Collin M, Esposito E, Bramanti P, Thiemermann C.
    J Pharmacol Exp Ther; 2006 Jul; 318(1):79-89. PubMed ID: 16601144
    [Abstract] [Full Text] [Related]

  • 8. Combination of dexamethasone and etanercept reduces secondary damage in experimental spinal cord trauma.
    Genovese T, Mazzon E, Crisafulli C, Esposito E, Di Paola R, Muià C, Di Bella P, Meli R, Bramanti P, Cuzzocrea S.
    Neuroscience; 2007 Nov 30; 150(1):168-81. PubMed ID: 17945432
    [Abstract] [Full Text] [Related]

  • 9. Fasudil protects hippocampal neurons against hypoxia-reoxygenation injury by suppressing microglial inflammatory responses in mice.
    Ding J, Li QY, Wang X, Sun CH, Lu CZ, Xiao BG.
    J Neurochem; 2010 Sep 30; 114(6):1619-29. PubMed ID: 20882700
    [Abstract] [Full Text] [Related]

  • 10. The effects of a polyphenol present in olive oil, oleuropein aglycone, in an experimental model of spinal cord injury in mice.
    Impellizzeri D, Esposito E, Mazzon E, Paterniti I, Di Paola R, Bramanti P, Morittu VM, Procopio A, Perri E, Britti D, Cuzzocrea S.
    Biochem Pharmacol; 2012 May 15; 83(10):1413-26. PubMed ID: 22342994
    [Abstract] [Full Text] [Related]

  • 11. Fasudil reduces GFAP expression after hypoxic injury.
    Kesherwani V, Tarang S, Barnes R, Agrawal SK.
    Neurosci Lett; 2014 Jul 25; 576():45-50. PubMed ID: 24905175
    [Abstract] [Full Text] [Related]

  • 12. Treatment of rat spinal cord injury with a Rho-kinase inhibitor and bone marrow stromal cell transplantation.
    Furuya T, Hashimoto M, Koda M, Okawa A, Murata A, Takahashi K, Yamashita T, Yamazaki M.
    Brain Res; 2009 Oct 27; 1295():192-202. PubMed ID: 19651108
    [Abstract] [Full Text] [Related]

  • 13. Immunomodulatory effects of etanercept in an experimental model of spinal cord injury.
    Genovese T, Mazzon E, Crisafulli C, Di Paola R, Muià C, Bramanti P, Cuzzocrea S.
    J Pharmacol Exp Ther; 2006 Mar 27; 316(3):1006-16. PubMed ID: 16303916
    [Abstract] [Full Text] [Related]

  • 14. Pretreatment of Rho kinase inhibitor inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in mice.
    Ding RY, Zhao DM, Zhang ZD, Guo RX, Ma XC.
    J Surg Res; 2011 Dec 27; 171(2):e209-14. PubMed ID: 21962807
    [Abstract] [Full Text] [Related]

  • 15. Role of Toll like receptor 4 signaling pathway in the secondary damage induced by experimental spinal cord injury.
    Impellizzeri D, Ahmad A, Di Paola R, Campolo M, Navarra M, Esposito E, Cuzzocrea S.
    Immunobiology; 2015 Sep 27; 220(9):1039-49. PubMed ID: 25990044
    [Abstract] [Full Text] [Related]

  • 16. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
    Arita R, Hata Y, Nakao S, Kita T, Miura M, Kawahara S, Zandi S, Almulki L, Tayyari F, Shimokawa H, Hafezi-Moghadam A, Ishibashi T.
    Diabetes; 2009 Jan 27; 58(1):215-26. PubMed ID: 18840783
    [Abstract] [Full Text] [Related]

  • 17. Beneficial effects of ethyl pyruvate in a mouse model of spinal cord injury.
    Genovese T, Esposito E, Mazzon E, Di Paola R, Meli R, Caminiti R, Bramanti P, Fink MP, Cuzzocrea S.
    Shock; 2009 Aug 27; 32(2):217-27. PubMed ID: 18948848
    [Abstract] [Full Text] [Related]

  • 18. Synergistic effects of bone marrow stromal cells and a Rho kinase (ROCK) inhibitor, fasudil on axon regeneration in rat spinal cord injury.
    Chiba Y, Kuroda S, Shichinohe H, Hokari M, Osanai T, Maruichi K, Yano S, Hida K, Iwasaki Y.
    Neuropathology; 2010 Jun 27; 30(3):241-50. PubMed ID: 19925560
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of tyrosine kinase-mediated cellular signalling by Tyrphostins AG126 and AG556 modulates secondary damage in experimental spinal cord trauma.
    Genovese T, Mazzon E, Esposito E, Muià C, Di Paola R, Crisafulli C, Bramanti P, Cuzzocrea S.
    Neuropharmacology; 2007 Jun 27; 52(7):1454-71. PubMed ID: 17418876
    [Abstract] [Full Text] [Related]

  • 20. Rho kinase inhibition by fasudil attenuates cyclosporine-induced kidney injury.
    Park JW, Park CH, Kim IJ, Bae EH, Ma SK, Lee JU, Kim SW.
    J Pharmacol Exp Ther; 2011 Jul 27; 338(1):271-9. PubMed ID: 21474569
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.